China Sunsine Chemical Holdings Ltd reported a 5% year-on-year increase in net profit to RMB 254.3 million for the six months ended Jun 30, 2026, as firmer average selling prices (ASP) and record sales volumes offset currency losses and higher research spending.

Group revenue climbed 19% YoY to RMB 2.01 billion, while earnings per share edged up to 26.67 RMB cents (SGD 5.07 cents). The board declared a one-tier tax-exempt special interim dividend of SGD 0.01 per ordinary share; no comparative figure for the prior-year interim was disclosed.

Revenue growth was underpinned by a 9% rise in ASP to RMB 16,586 per tonne and a 9% increase in total sales volume to an all-time half-year high of 119,959 tonnes. By product, accelerators contributed RMB 1.23 billion, up 22% YoY on a 12% volume gain to 59,148 tonnes. Insoluble sulphur sales nearly doubled to RMB 268.5 million on a 17% volume increase to 26,007 tonnes. Anti-oxidant revenue slipped 10% to RMB 448.1 million, mirroring a modest 2% decline in volume. Profit before income tax rose 4% to RMB 319.3 million after a RMB 48.6 million foreign-exchange loss linked to a stronger renminbi and higher R&D expenses.

Challenges during the period included rising raw-material costs following Middle East supply disruptions and intensified domestic competition. The company’s flexible pricing strategy helped preserve profitability, lifting gross profit by 22% to RMB 506.0 million and nudging gross margin to 25.2% from 24.6%.

To support future growth, China Sunsine is advancing several capacity-expansion projects. A 20,000-tonne-per-year continuous production line for high-quality solvent MBT at Weifang has begun trial runs and is expected to enter commercial production by end-2026. In Shandong, the conversion of a TBBS workshop to CBS has started commercial operations. These initiatives are projected to raise total annual capacity to 272,000 tonnes by FY2026, up 7% from the previous year.

Executive chairman Xu Cheng Qiu said the group’s resilience stemmed from reliable product quality, stable supply and responsive customer service, which allowed it to pass on higher costs and maintain competitiveness despite geopolitical tensions, trade protectionism and a slowing Chinese automotive market. He added that the “sales and production equilibrium” strategy, ongoing technological innovation and strong balance sheet—cash and bank balances stood at RMB 2.22 billion with no debt—position the company to pursue disciplined expansion and sustain long-term shareholder value amid uncertain market conditions.